Back to Search Start Over

Gliquidone ameliorates hepatic insulin resistance in streptozotocin-induced diabetic Sur1−/− rats.

Authors :
Zhang, Rui
Zhou, Xiaojun
Sheng, Qiqi
Zhang, Qian
Xie, Tianyue
Xu, Chunmei
Zou, Zhiwei
Dong, Jianjun
Liao, Lin
Source :
European Journal of Pharmacology. Sep2021, Vol. 906, pN.PAG-N.PAG. 1p.
Publication Year :
2021

Abstract

Gliquidone was suggested to exert hypoglycemic effect through enhancing hepatic insulin sensitivity. However, inadequate in vivo evidences make this statement controversial. The aim of the present study was to clarify the insulin-sensitizer role of gliquidone in liver and muscle, so as to confirm its extra-pancreatic effects in vivo. TALEN technique was used to create Sur1 knockout (Sur1 −/− ) rats. Diabetic Sur1 −/− rat models were established by high-fat diet combined with streptozotocin, and which were randomly divided into three groups: gliquidone, metformin and saline, treated for 8 weeks. Fasting blood glucose (FBG) and body mass were tested each week. IPGTT, IPITT and hyperinsulinemic-euglycemic clamp tests were used to evaluate glucose tolerance and insulin sensitivity, respectively. Key mediators of glucose metabolism in liver and skeletal muscle and the activity of AKT and AMPK in these tissues were further analyzed. We found that gliquidone decreased FBG and increased insulin sensitivity without increasing insulin secretion in diabetic Sur1 −/− rats. Further exploration implied that gliquidone mainly increased hepatic glycogen storage and decreased gluconeogenesis, which were accompanied with activation of AKT, but not enhanced muscle GLUT4 expression. However, both these effects were still weaker than that of metformin. These results suggested that gliquidone could exerts an extra-pancreatic hypoglycemic effect by improving insulin sensitivity, which might be largely attributes to its additional insulin sensitizer role in hepatic glucose metabolism. [Display omitted] • Gliquidone decreases the level of blood glucose through extra-pancreatic actions in diabetic Sur1 −/− rats. • Gliquidone alleviates hepatic insulin resistance by increasing glycogen synthesis and decreasing gluconeogenesis in vivo. • The mechanism of gliquidone might be related to the activation of AKT, rather than AMPK. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00142999
Volume :
906
Database :
Academic Search Index
Journal :
European Journal of Pharmacology
Publication Type :
Academic Journal
Accession number :
151349927
Full Text :
https://doi.org/10.1016/j.ejphar.2021.174221